Filtered By:
Condition: Migraine
Drug: Magnesium

This page shows you your search results in order of date.

Order by Relevance | Date

Total 9 results found since Jan 2013.

Complementary and supplementary procedures in the treatment of headache
Schmerz. 2023 Jul 11. doi: 10.1007/s00482-023-00738-1. Online ahead of print.ABSTRACTIn Germany, headache is one of the illnesses that most frequently leads to health impairments and to consultation with physicians. Even in children, headache is often associated with restricted activities of daily life. Nevertheless, the level of care for headache disorders is disproportionate to the medical needs. As a result, patients regularly use complementary and supportive therapeutic procedures. This review shows the procedures currently used for primary headache in childhood and adulthood, the methodological approaches and existing...
Source: Schmerz - July 11, 2023 Category: Anesthesiology Authors: Charly Gaul Laura Zaranek Gudrun Go ßrau Source Type: research

Magnesium in depression.
Abstract Magnesium is one of the most essential mineral in the human body, connected with brain biochemistry and the fluidity of neuronal membrane. A variety of neuromuscular and psychiatric symptoms, including different types of depression, was observed in magnesium deficiency. Plasma/serum magnesium levels do not seem to be the appropriate indicators of depressive disorders, since ambiguous outcomes, depending on the study, were obtained. The emergence of a new approach to magnesium compounds in medical practice has been seen. Apart from being administered as components of dietary supplements, they are also perc...
Source: Pharmacological Reports - August 23, 2013 Category: Drugs & Pharmacology Authors: Serefko A, Szopa A, Wlaź P, Nowak G, Radziwoń-Zaleska M, Skalski M, Poleszak E Tags: Pharmacol Rep Source Type: research

Prescription of Complementary and Alternative Medicine (CAM) in an Italian Cohort of Pediatric Headache Patients (P03.115)
CONCLUSIONS: Our study shows that CAM is widely used among pediatric headache patients, and physicians are mostly unaware of prescription. Further studies are required to investigate safety and efficacy of CAM, as a possible side-medicine to conventional pharmacological approach.Disclosure: Dr. Colombo has nothing to disclose. Dr. Dalla Libera has nothing to disclose. Dr. Pavan has nothing to disclose. Dr. Comi has received personal compensation for activities with Novartis, Teva Neuroscience, Sanofi-Aventis Pharmaceuticals, Inc., Merck Serono, and Bayer Schering.
Source: Neurology - February 14, 2013 Category: Neurology Authors: Colombo, B., Dalla Libera, D., Pavan, G., Comi, G. Tags: P03 Headache: Epidemiology Source Type: research